22nd Century Group (NASDAQ:XXII) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a research note published on Tuesday morning. The firm issued a sell rating on the biotechnology company’s stock. 22nd Century Group Trading Down 9.9 % XXII stock opened at $0.15 on Tuesday. The business’s 50 day simple moving average is $0.37 […]
22nd Century Group (NASDAQ:XXII) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a research note published on Tuesday morning. The firm issued a sell rating on the biotechnology company’s stock. 22nd Century Group Trading Down 9.9 % XXII stock opened at $0.15 on Tuesday. The business’s 50 day simple moving average is $0.37 […]
Leave a Reply
22nd Century Group (NASDAQ:XXII) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a research note published on Tuesday morning. The firm issued a sell rating on the biotechnology company’s stock. 22nd Century Group Trading Down 9.9 % XXII stock opened at $0.15 on Tuesday. The business’s 50 day simple moving average is $0.37 […]
Leave a Reply
22nd Century Group (NASDAQ:XXII) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a research note published on Tuesday morning. The firm issued a sell rating on the biotechnology company’s stock. 22nd Century Group Trading Down 9.9 % XXII stock opened at $0.15 on Tuesday. The business’s 50 day simple moving average is $0.37 […]